(Q37815481)

23 August 2017

1 reference

title

Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases (English)

1 reference

23 August 2017

0 references

1

Jagat R Kanwar

1 reference

23 August 2017

Rajiv R Mohan

2

1 reference

23 August 2017

Rupinder K Kanwar

series ordinal

3

1 reference

23 August 2017

Kislay Roy

series ordinal

4

1 reference

23 August 2017

Raj Bawa

series ordinal

5

1 reference

23 August 2017

publication date

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1435-1445

1 reference

Aptamers in research and drug development

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Therapeutic applications of aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Aptamers for Targeted Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Nucleic Acid Aptamers as Tools and Drugs: Recent Developments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Discovery and development of therapeutic aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Protein Detection with Aptamer Biosensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Label-free colorimetric detection of picomolar thrombin in blood plasma using a gold nanoparticle-based assay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Synthetic DNA aptamers to detect protein molecular variants in a high-throughput fluorescence quenching assay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Aptamer-functionalized nano-biosensors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Gold nanoparticle-based colorimetric and "turn-on" fluorescent probe for mercury(II) ions in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

The impact of Vision 2020 on global blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Stromal haze, myofibroblasts, and surface irregularity after PRK

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Growth factors: importance in wound healing and maintenance of transparency of the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Therapeutic monoclonal antibodies in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Safety profile of topical VEGF neutralization at the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Accelerated Color Change of Gold Nanoparticles Assembled by DNAzymes for Simple and Fast Colorimetric Pb2+Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Stimuli-Responsive Disassembly of Nanoparticle Aggregates for Light-Up Colorimetric Sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

Label-Free Colorimetric Detection of Lead Ions with a Nanomolar Detection Limit and Tunable Dynamic Range by using Gold Nanoparticles and DNAzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.115

21 January 2018

Identifiers

DOI

10.2217/NNM.10.115

1 reference

23 August 2017

1 reference